Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

Tilray and Curaleaf are expanding their presence in Europe, capitalizing on the rapidly growing cannabis market. Curaleaf announced a new supply agreement in the Czech Republic, while Tilray received approval for its first medical cannabis extract in Portugal. The European cannabis market surpassed €2 billion in 2023, with Germany, Czech Republic, Switzerland, and the Netherlands leading regulatory developments. The Benzinga Cannabis Capital Conference in Florida will further discuss these market dynamics.

Portfolio Pulse from Jelena Martinovic

March 14, 2024 | 2:58 pm

Tension between the White House and the DEA over marijuana rescheduling is increasing, with DEA officials questioning the medicinal benefits of cannabis despite HHS documents supporting its medical use. The DEA's resistance and concerns over THC potency have caused cannabis stocks to wobble, with notable dips in stocks like MSOS, CURLF, GTBIF, VRNOF, and TCNNF. Rescheduling cannabis could offer significant benefits for the industry, including federal tax deductions and more research opportunities, but faces legal and international treaty concerns.

Portfolio Pulse from Maureen Meehan

March 11, 2024 | 10:56 pm

Wedbush analyst Gerald Pascarelli maintains an Outperform rating on Curaleaf Holdings and raises the price target from $4.5 to $6.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 3:13 pm

Amsterdam will not participate in the Netherlands' legal cannabis trial, aimed at regulating and monitoring coffee shops. The trial, started in December 2023, allows legal operation across 10 municipalities but faced opposition. Italy launches a project to develop hemp supply chains in Sicily, funded by the EU and Sicilian Region. In the UK, cannabis clinics report an increase in ADHD patients due to medication shortages, with Curaleaf's research director commenting on the trend.

Portfolio Pulse from Nina Zdinjak

March 08, 2024 | 1:53 pm

President Joe Biden's State of the Union speech highlighted cannabis reform, sparking positive reactions from the cannabis industry. Ayr Wellness and Curaleaf, among others, expressed support and outlined the potential benefits of rescheduling cannabis, including tax savings and the establishment of national standards for cannabis testing.

Portfolio Pulse from Maureen Meehan

March 08, 2024 | 6:42 am

On March 7, 2024, several cannabis stocks experienced significant price movements. Notable gainers included AusCann Group Holdings, Elixinol Wellness, and Rocky Mountain High, with increases of 766.67%, 75.49%, and 66.67% respectively. Corbus Pharmaceuticals and Emeren Group also saw notable gains on NASDAQ and NYSE. Conversely, Global Hemp Group led the losers with a 48.89% decrease, followed by Item 9 Labs and Global Compliance. Other significant losers included 22nd Century Group and Neptune Wellness Solutions on NASDAQ.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 9:30 pm

Craig-Hallum analyst Eric Des Lauriers has maintained a Hold rating on Curaleaf Holdings (OTC:CURLF) and increased the price target from $2.75 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 4:49 pm

Needham analyst Matt McGinley has maintained a Buy rating on Curaleaf Holdings (OTC:CURLF) and increased the price target from $4.25 to $5.25.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 11:51 am

Curaleaf Holdings, Inc. (CURLF) reported a record Q4 revenue of $345 million, a slight year-over-year increase from $340.2 million. The company narrowed its net loss to $57.7 million, down from a larger loss in the previous year, and saw an adjusted EBITDA of $83 million. The positive results were attributed to disciplined teamwork and growth in key markets such as Arizona, Florida, New York, and Pennsylvania. For the full year, Curaleaf achieved a net revenue of $1.35 billion, a 6% increase from the previous year, with a net loss of $281.2 million.

Portfolio Pulse from Maureen Meehan

March 06, 2024 | 10:36 pm

Cannabis stocks experienced significant movements on March 6, 2024, with notable gainers including Item 9 Labs, Affinor Growers, and Rocky Mountain High, among others. Conversely, several companies faced declines, with AusCann Group Holdings leading the losers, followed by Elixinol Wellness and Neptune Wellness Solutions. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.